Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$41.92 - $58.18 $201,216 - $279,264
-4,800 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$44.23 - $57.5 $187,977 - $244,375
4,250 Added 772.73%
4,800 $248,000
Q4 2020

Feb 12, 2021

BUY
$33.21 - $46.54 $6,642 - $9,308
200 Added 57.14%
550 $24,000
Q1 2020

May 14, 2020

BUY
$31.52 - $53.81 $11,032 - $18,833
350 New
350 $12,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.